Investors

VolitionRx to use Expedeon’ Biotin Technology in its Epigenetic Research Kits

July 21st, 2013

In-licensing deal between VolitionRx and UK-based Expedeon helps drive development of novel cancer diagnostics VolitionRx Limited (OTC: VNRX), a life sciences company focused on the development of blood-based diagnostic tests, has signed a non-exclusive in-licensing agreement with Expedeon, a specialist provider of bioconjugation systems, based in Cambridge, UK. Under the agreement, Expedeon will supply its…

View

Gold nanoparticles: strange properties and applications in the Life Sciences

July 10th, 2013

**This webinar was produced by Innova Biosciences which is now fully integrated with their company, Expedeon Ltd., and have taken the Expedeon Ltd name and logo.   Gold nanoparticles exhibit extraordinary properties quite unlike those of the bulk metal. These properties can be exploited in a variety of assay applications,…

View